Skip to main content
. 2024 Jan 9;26:16. doi: 10.1186/s13075-023-03251-z

Fig. 1.

Fig. 1

Change in patients’ demographics and treatment from 2012 to 2021. A Box plots showing the change in the mean patient age. B Change in the proportion of age groups. C Percentage of patients treated with MTX, GCs, and b/tsDMARDs